The adaptive immune response is a highly specific defense mechanism of the immune system that develops in response to exposure to pathogens or foreign substances (antigens). It differs from the innate immune response in that it is slower to develop initially but provides long-lasting and targeted protection. Here’s a detailed overview:
Specificity – Targets specific antigens.
Memory – Responds more rapidly and strongly on subsequent exposures.
Diversity – Can recognize a vast array of antigens.
Self-tolerance – Normally does not attack the body's own tissues.
Occurs via B cell receptors (BCRs) and T cell receptors (TCRs).
B cells recognize free antigens.
T cells recognize processed antigens presented on MHC molecules:
MHC Class I presents to CD8+ cytotoxic T cells.
MHC Class II presents to CD4+ helper T cells.
Antigen-presenting cells (APCs), such as dendritic cells, process and present antigens to naïve T cells in lymphoid organs.
Requires two signals:
Signal 1: Binding of TCR or BCR to its specific antigen.
Signal 2: Co-stimulation (e.g., CD28 on T cells binding B7 on APCs).
Activated lymphocytes proliferate (clonal expansion) and differentiate.
CD4+ T helper (Th) cells differentiate into:
Th1 – activates macrophages (intracellular pathogens)
Th2 – activates eosinophils and B cells (parasites, allergies)
Th17 – recruits neutrophils (fungi and extracellular bacteria)
Tfh – helps B cells in germinal centers
Treg – suppresses immune responses to maintain tolerance
CD8+ T cells differentiate into cytotoxic T lymphocytes (CTLs) that kill infected cells.
B cells can differentiate into:
Plasma cells – produce antibodies.
Memory B cells – persist long-term for rapid future responses.
Antibodies (from plasma cells):
Neutralize pathogens or toxins.
Opsonize for phagocytosis.
Activate the complement system.
Cytotoxic T cells:
Induce apoptosis in infected or abnormal cells.
Helper T cells:
Activate macrophages, B cells, and cytotoxic T cells through cytokine secretion.
After pathogen clearance:
Most effector cells die (apoptosis).
Memory T and B cells remain in circulation and lymphoid tissues.
Memory cells respond more rapidly and effectively upon re-exposure to the same antigen.
Mediated by B cells and antibodies.
Effective against extracellular pathogens (e.g., bacteria, viruses in the bloodstream).
Mediated by T cells.
Effective against intracellular pathogens (e.g., viruses inside cells, tumor cells).
Vaccination leverages the adaptive immune system’s memory.
Autoimmune diseases arise from failure of self-tolerance.
Immunodeficiencies can impair adaptive responses (e.g., HIV targets CD4+ T cells).
Would you like a diagram to help visualize the process?
B cells recognize free antigens through specialized surface proteins called B cell receptors (BCRs). Here’s a detailed explanation of how this recognition occurs:
The BCR is a membrane-bound immunoglobulin (Ig) molecule—typically IgM or IgD in naïve B cells.
It is composed of:
Two identical heavy chains
Two identical light chains
A variable region (V region) at the tips of the chains that binds specifically to antigens.
Each B cell expresses a unique BCR due to genetic rearrangement during development (V(D)J recombination), enabling recognition of a specific antigen.
Unlike T cells, which require antigen presentation via MHC, BCRs can bind directly to free (soluble or particulate) antigens in their native conformation.
The epitope is the specific part of the antigen that is recognized by the BCR.
BCRs can recognize a wide range of antigen types, including:
Proteins
Polysaccharides
Lipids
Nucleic acids
Small molecules
Antigen Binding:
Antigen binds to the BCR's variable region.
This triggers cross-linking of adjacent BCRs if the antigen has multiple identical epitopes.
Signal Transduction:
The BCR is associated with signaling molecules (Igα and Igβ, also called CD79a and CD79b).
Antigen binding initiates a signaling cascade via these molecules, leading to B cell activation.
Antigen Internalization and Processing:
The bound antigen is internalized, processed, and its fragments are presented on MHC class II molecules.
Interaction with Helper T Cells (for protein antigens):
A CD4+ helper T cell recognizes the antigen-MHC II complex and provides a second signal (via CD40L-CD40 interaction and cytokines).
This fully activates the B cell, leading to:
Proliferation
Differentiation into plasma cells and memory B cells
Antibody class switching and affinity maturation (in germinal centers)
A B cell with a BCR specific for influenza hemagglutinin encounters the virus in lymphoid tissue.
It binds the hemagglutinin directly via its BCR.
After internalization and processing, the B cell presents a hemagglutinin peptide on MHC II to a Th cell.
The Th cell helps fully activate the B cell to become an antibody-secreting plasma cell.
Would you like an illustration showing this process?
Antigen processing, or the cytosolic pathway, is an immunological process that prepares antigens for presentation to special cells of the immune system called T lymphocytes.
This process involves two distinct pathways for processing of antigens from an organism's own (self) proteins or intracellular pathogens (e.g. viruses), or from phagocytosed pathogens (e.g. bacteria);
subsequent presentation of these antigens on class I or class II major histocompatibility complex (MHC) molecules is dependent on which pathway is used.
Both MHC class I and II are required to bind antigen before they are stably expressed on a cell surface. MHC I antigen presentation typically (considering cross-presentation) involves the endogenous pathway of antigen processing, and MHC II antigen presentation involves the exogenous pathway of antigen processing. Cross-presentation involves parts of the exogenous and the endogenous pathways but ultimately involves the latter portion of the endogenous pathway (e.g. proteolysis of antigens for binding to MHC I molecules).
While the joint distinction between the two pathways is useful, there are instances where extracellular-derived peptides are presented in the context of MHC class I and cytosolic peptides are presented in the context of MHC class II (this often happens in dendritic cells).
The antigen is recognized by two distinct sets of highly variable receptor molecules.
1. The antigen receptors on B cells
(The immunoglobulins that serve as
)2. The antigen-specific receptors of T cells.
antigen-specific receptors of T cells
T cells recognize only antigens that are displayed on cell surfaces.
These antigens may derive from pathogens that replicate within cells, such as viruses or intracellular bacteria, or from pathogens or their products that cells internalize by endocytosis from the extracellular fluid. T cells can detect the presence of intracellular pathogens because infected cells display on their surface peptide fragments derived from the pathogens' proteins.
These foreign peptides are delivered to the cell surface by specialized host-cell glycoproteins, the MHC molecules. The MHC glycoproteins are encoded in a large cluster of genes that were first identified by their potent effects on the immune response to transplanted tissues. For that reason, the gene complex was termed the major histocompatibility complex (MHC). We now know that within this region of the genome, in addition to those genes encoding the MHC molecules themselves, are many genes whose products are involved in the production of the MHC:peptide complexes.
Once an antigen has been recognized, the adaptive immune system creates an army of immune cells specifically designed to attack that antigen.
It is specific for the pathogen and confers protective immunity to reinfection with that pathogen.
Adaptive immunity can specifically recognize and destroy the pathogen because lymphocytes carry specialized cellular receptors and produce specific antibodies.
A protein that is produced in response to a particular pathogen is called the antibody, and the substance that induces the production of antibodies is called the antigen.
Paul Ehrlich coined the term antibody (in German Antikörper) in his side-chain theory at the end of the 19th century.[10] In 1899, Ladislas Deutsch (Laszlo Detre) (1874–1939) named the hypothetical substances halfway between bacterial constituents and antibodies "substances immunogenes ou antigenes" (antigenic or immunogenic substances). He originally believed those substances to be precursors of antibodies, just as zymogen is a precursor of an enzyme. But, by 1903, he understood that an antigen induces the production of immune bodies (antibodies) and wrote that the word antigen is a contraction of antisomatogen (Immunkörperbildner). The Oxford English Dictionary indicates that the logical construction should be "anti(body)-gen".[11]